EMEIS 13.500 € (-2,67 %) STIF 42.700 € (-2,18 %) FDJ UNITED 25.820 € (0,00 %) CEGEDIM 12.150 € (-0,82 %) 
FERROVIAL 56.520 € (-1,87 %) PULLUP ENTERTAIN 13.020 € (-1,96 %) CVC CAPITAL 11.100 € (-2,63 %) LOUIS HACHETTE 1.606 € (+1,61 %) FERMENTALG 0.521 € (-2,98 %) AUBAY 43.300 € (-1,93 %) SANOFI 82.400 € (-0,57 %) L'OREAL 353.975 € (-0,89 %) AKZO NOBEL 48.960 € (-3,81 %) LVMH 466.400 € (-1,00 %) AIRBUS 163.840 € (-2,42 %) VALBIOTIS 1.090 € (-0,18 %) SCHNEIDER ELECTRIC 231.500 € (-3,52 %) STELLANTIS NV 6.256 € (-1,06 %) FORVIA 9.938 € (-2,33 %) MAGNUM 12.490 € (+0,08 %) ASML HOLDING 1 141.200 € (-3,91 %) KPN KON 4.805 € (+0,75 %) ACCOR 41.620 € (-0,72 %) SARTORIUS STED BIO 165.450 € (-1,34 %) REXEL 33.700 € (-2,18 %) 
SHELL PLC 40.475 € (+2,40 %) ASR NEDERLAND 60.380 € (-0,56 %) COVIVIO 52.600 € (-1,50 %) HEIJMANS KON 77.000 € (-4,35 %) IPSEN 164.300 € (-0,48 %) AXA 39.970 € (-0,50 %) RELX 28.860 € (+0,42 %) LATECOERE 0.020 € (-0,51 %) AIR FRANCE -KLM 8.894 € (-4,59 %) 
J.MARTINS,SGPS 20.960 € (0,00 %) SAINT GOBAIN 70.520 € (-2,30 %) 
AEGON 6.324 € (-1,09 %) 2CRSI 28.350 € (-3,41 %) EUTELSAT COMMUNIC. 2.175 € (+1,16 %) ELIS 24.880 € (-0,64 %) WORLDLINE 0.273 € (+0,29 %) ENGIE 28.430 € (+0,11 %) ING GROEP N.V. 22.700 € (-2,30 %) TOTALENERGIES 79.340 € (+2,29 %) ABIONYX PHARMA 3.625 € (-1,49 %) NX FILTRATION 2.490 € (-0,20 %) UNILEVER 48.255 € (-0,09 %) NANOBIOTIX 28.150 € (-2,76 %) ABIVAX 97.300 € (-4,61 %) DBT 0.058 € (+12,70 %) AHOLD DEL 41.240 € (+0,10 %) SBM OFFSHORE 34.860 € (+0,98 %) EURAZEO 41.080 € (-1,49 %) BNP PARIBAS ACT.A 83.210 € (-2,54 %) ELIOR GROUP 2.528 € (-0,47 %) ALTAREA 113.600 € (-1,22 %) EUROFINS SCIENT. 65.640 € (+0,89 %) SOITEC 50.780 € (-4,33 %) BIOMERIEUX 92.800 € (+0,11 %) PHARMING GROUP 1.435 € (-1,64 %) |
30/03/2026 22:16
EQS-Adhoc: Knaus Tabbert AG Releases Forecast for Fiscal Year 2026EQS-Ad-hoc: Knaus Tabbert AG / Key word(s): Forecast / Full year Knaus Tabbert AG Releases Forecast for Fiscal Year 2026 The Management Board of Knaus Tabbert today approved the forecast for fiscal year 2026. Based on current business performance and internal planning, the Management Board expects consolidated revenue of approximately EUR 950 million and an adjusted EBITDA margin of 5.0% to 7.0% for the 2026 fiscal year. To align cost structures and production capacities with expected market demand, the Management Board has approved a comprehensive package of measures. This program includes, in particular, the relocation of production of certain product lines, organizational adjustments combined with overhead cost reduction, productivity improvements, adjustments to fixed and variable employee compensation, savings in other operating expenses, and measures to increase margins. Achieving the forecast is among other things contingent upon the planned implementation of the approved measures. End of Inside Information 30-March-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
2300814 30-March-2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière